Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
NCT Number: NCT06104657
This study examines qualitative techniques in defining meaningful within patients changes in symptoms in patients with cancer that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced). This study may help researcher better understand how to interpret reports from patients about their cancer symptoms and treatment side effects.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Rochester, Minnesota, 55905, United States
PRIMARY OBJECTIVES:
I. To develop method to establish meaningful change in patient-reported outcomes (PROs).
II. To provide responder definitions in 2 ways:
IIa: Detectable change: within patient score change patients perceive but does not exceed a subjective threshold for a modification to patient care (for worsening) or conclusion of achieving therapeutic benefit (for improvement); IIb. Meaningful change: within patient score change that patients perceive and that does require modification in management (for worsening) or supports conclusion of therapeutic benefit (improvement).
OUTLINE: This is an observational study. Participants are assigned to 1 of 2 groups.
PATIENTS: Patients take part in an interview on study.
PATIENT ADVOCATES: Patient advocate participants take part in an interview on study.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Non-interventional study
Time frame: Baseline
Change in PROs will be assessed using the critical incident technique (CIT) during semi-structured interviews as a means of educating, training, and evaluating patients on the concept of meaningful change. Interviews will be summarized to record how patients explain the concept of meaningful improvement and declines in their own words.
Time frame: Baseline
PRO-CTCAE is a patient-reported outcome (PRO) measurement system developed to evaluate symptomatic toxicity in patients on cancer clinical trials. It was designed to be used as a companion to the Common Terminology Criteria for Adverse Events (CTCAE). Scores will be evaluated for worsening from good days (baseline) and improvement from bad days (baseline).
Time frame: Baseline
The Functional Assessment of Cancer Therapy - General (FACT-G) is a 27-item questionnaire that measures four domains of Health-Related Quality of Life (HRQOL) in cancer patients: physical, social, emotional, and functional well-being. Questions are answered with a 0-4 scale where 0=Not at all and 4=Very much. Scores will be evaluated for worsening from good days (baseline) and improvement from bad days (baseline).
Mayo Clinic
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06305884
Hematopoietic and Lymphoid System Neoplasm, Hemic and Lymphatic Diseases
Columbus, Ohio, United States
View Trial DetailsNCT06030427
Hematopoietic and Lymphoid System Neoplasm, Malignant Solid Neoplasm
La Crosse, Wisconsin, United States
View Trial DetailsNCT06073951
Hematopoietic and Lymphoid System Neoplasm, Malignant Solid Neoplasm
Scottsdale, Arizona, United States
View Trial DetailsNCT06063603
Blood Protein Disorders, Cardiovascular Diseases
Scottsdale, Arizona, United States
View Trial Details